A phase II study evaluating Wafermine in patients with treatment resistant depression
Latest Information Update: 27 May 2019
At a glance
- Drugs Ketamine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
Most Recent Events
- 21 May 2019 According to a iX Biopharma media release, the company to ready to start the phase II studies for this indication.